Almitrine in the treatment of chronic obstructive pulmonary disease with hypoxaemia - A clinical multicentre study comparing two dosages;ALMITRIN IN DER THERAPIE CHRONISCH-OBSTRUKTIVER ATEMWEGSERKRANKUNGEN MIT HYPOXAMIE - EINE KLINISCHE MULTICENTER-STUDIE ZUM VERGLEICH ZWEIER DOSIERUNGEN

Pneumologie

Volumn 52, Issue 3, 1998, Pages 121-127

  Nowak, D ^a,b   Wywiol, Anett ^a   Magnussen, H ^a  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALMITRINE; CARBON DIOXIDE; OXYGEN;

ADULT; AGED; ARTICLE; BLOOD GAS ANALYSIS; CARBON DIOXIDE TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUROLOGIC EXAMINATION; OXYGEN TENSION; PATIENT COMPLIANCE; PATIENT MONITORING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPIROMETRY; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

AGED; ALMITRINE; ANOXEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; OXYGEN; PROSPECTIVE STUDIES; RESPIRATORY SYSTEM AGENTS; TREATMENT OUTCOME;

EID: 0031909755     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Allen, M. B., K. Prowse: Peripheral nerve function in patients with chronic bronchitis receiving Almitrine or Plazebo. Thorax 44 (1989) 292-297
2. Ansquer, J. C.: A one-year double-blind placebo-controlled study of the efficacy and safety of Almitrine bismesylate in hypoxic COLD patients. Monitoring progress status on 490 patients entered into the VIMS study before January 1st, 1984. Eur. J. Respir. Dis. Suppl. 146 (1986) 703-712
3. ATS = American Thoracic Society, Medical Section of the American Lung Association: ATS statement - Snowbird workshop on standardization of spirometry. Am. Rev. Respir. Dis. 119 (1979) 831-838
4. Bakran, I., B. Vrhovac, B. Stangl, D. Tabori, A. Ivicevic, V. Todic, F. Kandare: Double-blind placebo controlled clinical trial of Almitrine bismesylate in patients with chronic respiratory insufficiency. Eur. J. Clin. Pharmacol. 38 (1990) 249-253
5. Bardsley, P. A., P. Howard, W. De Backer, P. Vermeire, M. Mairesse, C. Ledent, M. Radermecker, T. Bury, J. Ansquer: Two years treatment with Almitrine bismesylate in patients with hypoxic chronic obstructive airways disease. Eur. Respir. J. 4 (1991) 308-310
6. Baune, A., N. Bromet, S. Courte: Trace determination of Almitrine in plasma by gas-liquid chromatography using a nitrogen-phosphorus detector. J. Chromatography 223 (1981) 219-224
7. Bird, C. M., S. M. Revill, D. D. Vara, M. D. L. Morgan: The effect of a time delay on the measurement of capillary blood gases. Respir. Med. 90 (1996) 107-109
8. Bouche, P., L. Lacomblez, J. M. Leger, M. P. Chaunu, H. Ratinahirana, P. Brunet, J. J. Hauw, H. P. Cathala, D. Laplane: Peripheral neuropathies during treatment with Almitrine: Report of 46 cases. J. Neurol. 236 (1989) 29-33
9. Bourgouin-Karaouni, D., J. Mercier, C. Prefaut: Long term studies on Almitrine bismesylate in COPD patients. Eur. J. Respir. Dis. Suppl. 146 (1986) 695-701
10. Bury T., J. P. Jeannot, J. C. Ansquer, M. Radermecker: Dose-response and pharmacokinetic study with Almitrine bismesylate after single oral administrations in COPD patients. Eur. Respir. J. 2 (1989) 49-55
11. Castaing, Y., C. Manier, H. Guenard: Improvement in ventilation-perfusion relationships by Almitrine in patients with chronic obstructive pulmonary disease during mechanical ventilation. Am. Rev. Respir. Dis. 134 (1986) 910-916
12. Chedru, F., R. Nodzenski, J. F. Dunand, G. Amarenco, R. Ghnassia, C. Ciaudo-Lacroix, C. Said: Peripheral neuropathy during treatment with Almitrine. Br. Med. J. 290 (1985) 896
13. Chen, L., F. L. Miller, W. R. Clarke, F. X. Clergue, C. Marshall, B. E. Marshall: Low-dose Almitrine bismesylate enhances hypoxic pulmonary vasoconstriction in closed-chest dogs. Anesth. Analg. 71 (1990) 475-483
14. De Backer, W., P. Vermeire, E. Bogaert, E. Janssens, R. van Maele: Almitrine has no effect on gas exchange after bilateral carotid body resection in severe chronic airflow obstruction. Bull. Eur. Physiopathol. Respir. 21 (1985) 427-432
15. Evans, T. W., J. Tweney, J. C. Waterhouse, A. J. Suggett., A. Nicholl, P. Howard: The interaction of long term domiciliary oxygen therapy and Almitrine bismesylate in hypoxic cor pulmonale. Eur. J. Respir. Dis. Suppl. 146 (1986) 665-669
16. Evans, T. W., J. Tweney, J. C. Waterhouse, J. Nichol, A. J. Suggett, P. Howard: Almitrine bismesylate and oxygen therapy in hypoxic cor pulmonale. Thorax 45 (1990) 16-21
17. Gerard, M., P. Leger, J. C. Couturier, D. Robert: Ten cases of peripheral neuropathy during treatment with Almitrine in COPD patients. Eur. J. Respir. Dis. Suppl. 146 (1986) 591-596
18. Gherardi, R., F. Louarn, C. Benvenuti, M. Perrier, J. L. Lejonc, A. Schaeffer, J. D. Degos: Peripheral neuropathy in patients treated with Almitrine bimesylate. Lancet 1 (1985) 1247-1250
19. Gothe, B., N. S. Cherniack, R. T. Bachand Jr., M. B. Szalkowski, K. A. Bianco: Long-term effects of Almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease. Am. J. Med. 84 (1988) 436-444
20. Howard, P.: Summary/conclusions. Bull. Eur. Physiopathol. Respir. 23, suppl. 11, (1987) 215-217
21. 2 and Almitrine in the cat carotid chemoreceptors. J. Appl. Physiol. 67 (1989) 232-238
22. Lerebours, C., N. Moore, J. Senant: Almitrine and peripheral nerve function. Lancet 1 (1988) 799-800
23. Ludin, H. P.: Electromyography in practice. Thieme Stratton, New York 1980
24. Ludin, H. P., W. Tackmann: Sensory neurography. Thieme Stratton, New York 1981
25. Medical Research Council: Domiciliary oxygen trial. Lancet 1 (1981) 681-685
26. Nocturnal Oxygen Therapy Trial Group: Continuous or nocturnal oxygen therapy in hypoxaemic chronic obstructive lung disease. Ann. Intern. Med. 93 (1970) 394-399
27. Nowak, D., M. Bruch, F. Arnaud, H. Fabel, D. Kiessling, D. Nolte, A. Overlack, M. Rolke, W. T. Ulmer, H. Worth, A. Wywiol, I. Zimmermann, H. Magnussen: Peripheral neuropathies in patients with chronic obstructive pulmonary disease: A multicenter prevalence study. Lung 168 (1990) 43-51
28. Payen, D. M., C. Gatecel, N. Kermarrec, S. Beloucif: Almitrine and inhaled nitric oxide in acute respiratory failure. In: W. M. Zapol, K. D. Bloch (Hrsg.): Nitric oxide and the lung. Marcel Dekker, New York (1997) 313-332
29. Pfeiffer, G., K. Kunze, M. Brüch, M. Kutzner, G. Ladurner, J. P. Malin, W. Tackmann: Polyneuropathy associated with chronic hypoxaemia: Prevalence in patients with chronic obstructive pulmonary disease. J. Neurol. 237 (1990) 230-233
30. Quanjer, Ph. H., G. H. Tammeling, J. E. Cotes, O. F. Pedersen, R. Peslin, J.-C. Yernault: Lung volumes and forced ventilatory flows. Eur. Respir. J. 6, suppl. 16 (1993) 5-40
31. Radermecker, M. F.: Introduction. In: Radermecker, M. F., J. R. Thomas: Chronic obstructive pulmonary disease and Almitrine bismesylate. Servier Benelux, Brüssel 1986
32. Saadjian, A. Y., F. F. Philip-Joel, A. Barret, S. Levy, A. G. Arnaud: Effect of Almitrine bismesylate on pulmonary vasoreactivity to hypoxia in chronic obstructive pulmonary disease. Eur. Respir. J. 7 (1994) 862-868
33. Voisin, C., P. Howard, J. C. Ansquer: Almitrine bismesylate: A long-term placebo-controlled double-blind study in COAD -Vectarion International Multicentre Study Group. Bull. Eur. Physiopathol. Respir. 23, suppl. 11 (1987) 169-182
34. Watanabe, S., R. E. Kanner, A. G. Cutillo, R. L. Menlove, R. T. Bachand Jr., M. B. Szalkowski, A. D. Renzetti Jr.: Long-term effect of Almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 140 (1989) 1269-1273
35. Winkelmann, B. R., Th. H. Kullmer, D. G. Kneissl, D. Trenk, H. Kronenberger: Low-dose Almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease. Chest 105 (1994) 1383-1391
36. Wuttke, R., P. von Wiehert: Almitrine bismesylate bei chronisch-obstuktiven Atemwegserkrankungen und bestehender Hypoxämie. Respiration 48 (1985) 285-295